Zomedica Pharmaceuticals Corp (ZOM) Stock
ZOM is no longer traded. Zomedica Pharmaceuticals was delisted from the NYSE American in May 2025.
Prices on this page are historical; the last trade was May 5, 2025 at $0.06.
Zomedica Pharmaceuticals stock price history
ZOM final trading statistics
- Final close
- $0.06
- Final trading day
- May 5, 2025
- Market cap at delisting
- $53.90M
- Shares outstanding
- 979.95M
- Final 52-week range
- $0.02 – $0.20
- Avg. volume (final 3 mo.)
- 6,152,900
- All-time high (split-adj.)
- $2.98 · Jun 2018
- All-time low (split-adj.)
- $0.03 · Mar 2025
- Return since IPO
- -93.4%
- Beta
- 1.16
- Book value / share
- $0.21
- Price / book
- 0.27
Zomedica Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $27.29M | -$47.0M | — |
| FY2023 | $25.19M | -$34.5M | -$0.03 |
| FY2022 | $18.93M | -$17.0M | -$0.02 |
| FY2021 | $4.13M | -$18.4M | -$0.05 |
| FY2020 | $14.1K | -$16.9M | -$0.06 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Zomedica Pharmaceuticals Corp
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.
Zomedica Pharmaceuticals stock FAQ
What happened to Zomedica Pharmaceuticals stock?
Zomedica Pharmaceuticals stock was delisted from the NYSE American. Its final close was $0.06 on May 5, 2025.
Is ZOM stock still trading?
No. ZOM was delisted from the NYSE American in May 2025 and no longer trades on a U.S. exchange.
What was the last price of ZOM stock?
ZOM closed at $0.06 on its final trading day, May 5, 2025, for a market value of about $53.90M.
What were Zomedica Pharmaceuticals's revenue and earnings in its last full fiscal year?
Zomedica Pharmaceuticals reported revenue of $27.29M and net income of -$47.0M in fiscal 2024, its last full year as a public company.
When did Zomedica Pharmaceuticals go public?
Zomedica Pharmaceuticals Corp stock began trading on July 29, 2016.